Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe-Reference-Cited by-同舟云学术

Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe

Published:2011-03 Issue:3 Volume:59 Page:342-352
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Chapple Christopher R.,Montorsi Francesco,Tammela Teuvo L.J.,Wirth Manfred,Koldewijn Evert,Fernández Fernández Eldiberto

Publisher

Elsevier BV

Subject

Urology

Reference37 articles.

1. Medical treatment for benign prostatic hyperplasia;Chapple;BMJ,1992

2. Medical therapy for benign prostatic hyperplasia: a review of the literature;Clifford;Eur Urol,2000

3. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia;Barry;J Urol,1993

4. The International Continence Society “Benign Prostatic Hyperplasia” Study: the botherosomeness of urinary symptoms;Peters;J Urol,1997

5. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines);Madersbacher;Eur Urol,2004

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia;Journal of Ethnopharmacology;2024-08

2. No clinical benefit from sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) than BCG alone in the adjuvant treatment of high risk non muscle invasive bladder cancer: result of a planned interim analysis of a prospective randomized trial;Minerva Urology and Nephrology;2024-07

3. Isoform‐independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells;The FASEB Journal;2024-04-09

4. Characteristics of α₁‐adrenoceptor antagonists‐induced ejaculatory dysfunction on spontaneous seminal emission in rats;Basic & Clinical Pharmacology & Toxicology;2024-02-26

5. Management of lower urinary tract symptoms in Parkinsonian disorders;Revue Neurologique;2024-01